JP2016508502A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508502A5
JP2016508502A5 JP2015556128A JP2015556128A JP2016508502A5 JP 2016508502 A5 JP2016508502 A5 JP 2016508502A5 JP 2015556128 A JP2015556128 A JP 2015556128A JP 2015556128 A JP2015556128 A JP 2015556128A JP 2016508502 A5 JP2016508502 A5 JP 2016508502A5
Authority
JP
Japan
Prior art keywords
silica gel
composition
liquid material
gel particles
inorganic oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508502A (ja
JP6513031B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/013848 external-priority patent/WO2014120922A1/en
Publication of JP2016508502A publication Critical patent/JP2016508502A/ja
Publication of JP2016508502A5 publication Critical patent/JP2016508502A5/ja
Application granted granted Critical
Publication of JP6513031B2 publication Critical patent/JP6513031B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556128A 2013-02-01 2014-01-30 液体テクノロジーのための担体としての多孔質シリカゲル Active JP6513031B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361759723P 2013-02-01 2013-02-01
US61/759,723 2013-02-01
PCT/US2014/013848 WO2014120922A1 (en) 2013-02-01 2014-01-30 Porous silica gel as a carrier for liquid technologies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018197017A Division JP6861679B2 (ja) 2013-02-01 2018-10-18 液体テクノロジーのための担体としての多孔質シリカゲル

Publications (3)

Publication Number Publication Date
JP2016508502A JP2016508502A (ja) 2016-03-22
JP2016508502A5 true JP2016508502A5 (enExample) 2018-12-13
JP6513031B2 JP6513031B2 (ja) 2019-05-15

Family

ID=51262940

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015556128A Active JP6513031B2 (ja) 2013-02-01 2014-01-30 液体テクノロジーのための担体としての多孔質シリカゲル
JP2018197017A Active JP6861679B2 (ja) 2013-02-01 2018-10-18 液体テクノロジーのための担体としての多孔質シリカゲル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018197017A Active JP6861679B2 (ja) 2013-02-01 2018-10-18 液体テクノロジーのための担体としての多孔質シリカゲル

Country Status (9)

Country Link
US (1) US10660856B2 (enExample)
EP (1) EP2950923B1 (enExample)
JP (2) JP6513031B2 (enExample)
KR (1) KR102229036B1 (enExample)
CN (2) CN111389345A (enExample)
ES (1) ES2908958T3 (enExample)
HK (1) HK1217927A1 (enExample)
PL (1) PL2950923T3 (enExample)
WO (1) WO2014120922A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017185040A1 (en) * 2016-04-22 2017-10-26 University Of Mississippi Twin-screw dry granulation for producing solid formulations
AU2018325148B2 (en) * 2017-09-01 2024-08-01 Jw Pharmaceutical Corporation Solid preparation comprising dutasteride and method for preparing same
EP3862318A4 (en) * 2018-10-05 2022-06-15 Fuji Chemical Industry Co., Ltd. Porous silica particle composition
IL282213B2 (en) 2018-10-16 2025-07-01 Silicycle Inc A tunable process for the preparation and use of silica capsules/spheres
KR20210089210A (ko) 2018-11-07 2021-07-15 디스럽티브 매터리얼즈 파마 아베 실질적 비정질인 메조포러스 탄산마그네슘을 포함하는 신규한 비정질 활성 제약 성분
CN111751480B (zh) * 2020-07-16 2021-06-15 北京理工大学 一种维生素e琥珀酸聚乙二醇酯的应用
WO2022026591A1 (en) * 2020-07-29 2022-02-03 Kydes Pharmaceuticals, Llc Pharmaceutical formulations comprising tadalafil
GB202014184D0 (en) * 2020-09-09 2020-10-21 Johnson Matthey Plc Modifed catalyst supports and catalysts supported thereon
JP7575266B2 (ja) * 2020-12-25 2024-10-29 Ａｇｃ株式会社 シリカ粒子及びその用途、並びにシリカ粒子の製造方法
EP4499286A1 (en) * 2022-11-14 2025-02-05 Medisca Pharmaceutique Inc. Methods and systems for making oil-loaded powders and use thereof
CN116159031B (zh) * 2023-02-22 2023-08-22 上海国创医药股份有限公司 一种马来酸氟伏沙明片剂及其制备方法
GB2634526A (en) 2023-10-11 2025-04-16 Univ Sheffield A method of manufacturing porous silicon

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU505536B2 (en) 1975-03-12 1979-11-22 J.M. Huber Corp. Methods for production and use of siliceous products
US4226743A (en) 1979-03-12 1980-10-07 W. R. Grace & Co. Silica-alumina hydrogel catalyst
US4629588A (en) * 1984-12-07 1986-12-16 W. R. Grace & Co. Method for refining glyceride oils using amorphous silica
US5256386A (en) * 1987-06-29 1993-10-26 Eka Nobel Ab Method for preparation of silica particles
ES2041616T3 (es) * 1991-03-16 1998-04-16 Torf Ets Productos bioactivos derivados de turba y composiciones farmaceuticas y cosmeticas que los contienen.
DE4429644A1 (de) * 1994-08-20 1996-02-22 Sued Chemie Ag Iodadsorptionsmittel
US6096337A (en) 1996-06-10 2000-08-01 Spireas; Spiridon Liquisolid systems and methods of preparing same
US5800834A (en) 1996-06-10 1998-09-01 Spireas; Spiridon Liquisolid systems and methods of preparing same
JPH10130013A (ja) * 1996-09-09 1998-05-19 Toyota Central Res & Dev Lab Inc クラスター包接材料
FR2767071B1 (fr) * 1997-08-06 1999-09-10 Rhodia Chimie Sa Composition comprenant un liquide absorbe sur un support a base de silice precipitee
JPH11157827A (ja) * 1997-11-21 1999-06-15 Shionogi & Co Ltd 新規二酸化ケイ素
SE9704400D0 (sv) 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6573032B1 (en) * 1999-04-22 2003-06-03 J. M. Huber Corporation Very high structure, highly absorptive hybrid silica and method for making same
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6790814B1 (en) 1999-12-03 2004-09-14 Procter & Gamble Company Delivery system having encapsulated porous carrier loaded with additives, particularly detergent additives such as perfumes
GB2365769A (en) 2000-08-18 2002-02-27 Secr Defence Skin preparations containing silicon
DE10153078A1 (de) * 2001-10-30 2003-05-22 Degussa Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
AU2002343555A1 (en) * 2001-11-14 2003-05-26 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
EP1358805A1 (en) * 2002-04-30 2003-11-05 Aventis Animal Nutrition S.A. Animal feed supplement
DE10244397A1 (de) 2002-09-24 2004-04-01 Basf Ag Cholinascorbat-Formulierungen
FR2850576B1 (fr) 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
CA2516096A1 (en) 2003-02-19 2004-09-02 Lifecycle Pharma A/S Use of a silica or silica derivative as a sorption material
FR2851918B1 (fr) * 2003-03-06 2006-06-16 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
WO2004084844A2 (en) 2003-03-27 2004-10-07 Dow Corning Corporation Controlled release compositions
GB0312703D0 (en) 2003-06-03 2003-07-09 Oxonica Ltd Agricultural compositions
JP2005053728A (ja) * 2003-08-01 2005-03-03 Dsl Japan Co Ltd 高吸油性および高い構造性を有する非晶質シリカ粒子
JP2005053744A (ja) * 2003-08-05 2005-03-03 Dsl Japan Co Ltd 高吸油性非晶質シリカ粒子
WO2005026048A1 (ja) * 2003-09-11 2005-03-24 Taiyo Kagaku Co., Ltd. 物質担持多孔質シリカ
EP1677828B1 (en) 2003-10-21 2012-12-26 PSIMedica Limited Composite material comprising a porous semiconductor impregnated with an organic substance
GB0406819D0 (en) 2004-03-26 2004-04-28 Dow Corning Controlled release compositions
JP2005307120A (ja) 2004-04-26 2005-11-04 Mitsubishi Chemicals Corp 徐放剤及びそれを用いた徐放材
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
CN100352430C (zh) * 2005-03-09 2007-12-05 山东大学 姜黄素自微乳化制剂及其制备方法
WO2006119779A2 (en) 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
FR2894822B1 (fr) 2005-12-20 2011-11-18 Pf Medicament Composition pharmaceutique contenant des acides gras omega-3
US8920821B2 (en) 2006-04-14 2014-12-30 Perrigo Israel Pharmaceuticals Ltd. Pharmaceutical compositions comprising silica microspheres
US20090181076A1 (en) 2006-05-04 2009-07-16 University Of South Australia Drug Release From Nanoparticle-Coated Capsules
US7691400B2 (en) 2006-05-05 2010-04-06 Medtronic Vascular, Inc. Medical device having coating with zeolite drug reservoirs
DE102006039273A1 (de) * 2006-08-22 2008-02-28 Evonik Degussa Gmbh Pyrogenes Siliciumdioxid zur Verwendung als Hilfsstoff in pharmazeutischen und kosmetischen Zusammensetzungen
KR20080026754A (ko) * 2006-09-21 2008-03-26 주식회사 삼양사 생물학적 활성성분을 함유하는 방출 제어형 입자, 및 이의제조방법
US20100136124A1 (en) 2007-04-20 2010-06-03 University Of South Australia Nanoparticle-coated capsule formulation for dermal drug delivery
US20100298447A1 (en) 2007-11-02 2010-11-25 Takeru Fujii Composite product of low-solubility drug and surfactant, and process for production thereof
EP2072042A1 (en) * 2007-12-21 2009-06-24 Lek Pharmaceuticals D.D. Active pharmaceutical ingredient on solid support, amorphous and with improved solubility
KR100950548B1 (ko) * 2008-01-10 2010-03-30 연세대학교 산학협력단 다공성 중공 실리카 나노입자, 그의 제조 방법, 상기를포함하는 약물 전달체 및 약제학적 조성물
DE102008000290A1 (de) 2008-02-13 2009-08-20 Evonik Degussa Gmbh Lagerstabile Produktsyteme für Prämixformulierungen
AU2009224418B2 (en) 2008-03-11 2014-12-11 Aska Pharmaceutical Co., Ltd. Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
US8188022B2 (en) 2008-04-11 2012-05-29 Amcol International Corporation Multilayer fragrance encapsulation comprising kappa carrageenan
US8778400B2 (en) 2008-04-21 2014-07-15 University Of South Australia Nanoparticle-stabilized capsule formulation for treatment of inflammation
CA2733297A1 (en) 2008-08-12 2010-02-18 Castle Beach, L.L.C. Active delivery system formulations
GB0821928D0 (en) 2008-12-01 2009-01-07 Isis Innovation Antibiotic nanomaterial
DE102010003204A1 (de) * 2010-03-24 2011-12-15 Evonik Degussa Gmbh Grobteilige Trägerkieselsäuren
CN103038168B (zh) * 2010-05-21 2016-11-09 格雷斯股份有限两合公司 多孔无机氧化物颗粒及其制造和使用方法
ES2658913T3 (es) 2010-09-07 2018-03-12 Emplicure Ab Dispositivo de administración transdérmica de un fármaco
US9980481B2 (en) 2012-04-02 2018-05-29 Basf Se Granules obtainable by milling pesticide and silica, addition of adjuvant, and fluidized bed granulation

Similar Documents

Publication Publication Date Title
JP2016508502A5 (enExample)
JP4708332B2 (ja) 推進剤としてヒドロフルオロアルカンを用いる計量式吸入器のための調合物
JP6861679B2 (ja) 液体テクノロジーのための担体としての多孔質シリカゲル
JP5661640B2 (ja) 薬学的懸濁物
JP2016514686A5 (enExample)
WO2012051426A3 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
JP2012511009A5 (enExample)
JP2002501885A5 (enExample)
TW201014612A (en) Stabilized pharmaceutical sub-micron suspensions and methods of forming same
Deliormanlı et al. Flow behavior and drug release study of injectable pluronic F-127 hydrogels containing bioactive glass and carbon-based nanopowders
CN1162157C (zh) 无氯氟烃的糠酸莫米他松气溶胶制剂
Rachmawati et al. Formulation of tablet containing curcumin nanoemulsion
TW524694B (en) Porous inorganic particles as carriers for drug substances
JP6686023B2 (ja) 生物活性剤または生物活性剤類を送達する組成物および方法
Hildgen et al. A new gradient matrix: formulation and characterization
Ibrahim Formulation and evaluation of mefenamic acid sustained release matrix pellets
JP5297194B2 (ja) 初期溶解率が改善されたプランルカスト固体分散体の薬剤学的組成物およびその製造方法
TW201735902A (zh) 油性組合物
JP5650434B2 (ja) 顆粒状入浴剤
TW202200117A (zh) 顆粒及使用其之製劑
JP2009209048A (ja) 医薬用酸化マグネシウム
CN104661652B (zh) 包含至少一种水溶性维生素e衍生物和至少一种亲水聚合物的储存稳定的无粉尘均质颗粒状配制剂
Daravath et al. Formulation and evaluation of meclizine hydrochloride fast dissolving tablets using solid dispersion method
JP2024063111A (ja) 顆粒及びそれを用いた製剤
ES2776208T3 (es) Procedimiento de mezcladura de polvo seco